Capital markets lawyers in Hong Kong are bullish about deal flow this year, as new listing rules are expected to attract more initial public offerings from tech and biotech companies.
The Hong Kong Stock Exchange announced on Tuesday that a set of new listing rules would take effect on April 30. The new regime will accept applicants with dual-class shares, a structure preferred by many startups and one that allows biotech companies with no revenue to list.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]